The β-adrenoceptor subtype that mediates adrenaline-induced relaxation was pharmacologically identified in smooth muscle cells of the isolated guinea-pig trachea. Adrenaline produced a concentration-dependent relaxation with a pD2 value of 7.1. The concentration-response curve for adrenaline was shifted rightwards in a competitive fashion by the β1-/β2-nonselective antagonists propranolol and bupranolol, with pA2 values of 8.85 and 8.97, respectively. Adrenaline-induced relaxation was not affected by the β1-selective antagonists atenolol and CGP-20,712A within the concentration ranges supposed to antagonize the β1-subtype (atenolol, ≤ 10 -6 M; CGP-20,712A, ≤ 10 -8 M). By contrast, the concentration-response curve for adrenaline was shifted rightwards in a competitive fashion by atenolol at concentrations ≥ 3 × 10 -6 M with a pA2 value of 5.77.
Introduction
The β-adrenoceptor is a member of the G-protein coupled receptor (GPCR) family and is now classified into three subtypes (β1, β2 and β3) (Arch and Kaumann, 1993; Johnson, 1998; Nagatomo and Koike, 2000) . Of these subtypes, the β2-adrenoceptor plays the most important Correspondence to: Yoshio Tanaka, Ph.D., Department of Chemical Pharmacology, Toho University School of Pharmaceutical Sciences, Miyama 2-2-1, Funabashi-City, Chiba 274-8510, Japan. Phone: +81-47-472-1435 +81-47-472- Fax: +81-47-472-1448 role in the relaxation of airway smooth muscle (Johnson, 1998; Lands et al., 1967; Nagatomo and Koike, 2000; Torphy, 1994) . This view is supported by the following evidence: 1) the three catecholamines that produce airway smooth muscle relaxation are ranked in potency as isoprenaline > adrenaline > noradrenaline (Lands et al., 1967; Nagatomo and Koike, 2000; Tanaka et al., 2003) ; 2) β2-receptors are richly expressed in airway smooth muscle (Barnes, 1993; Johnson, 1998; Nagatomo and Koike, 2000; Nijkamp, 1993) ; 3) β2-selective adrenoceptor agonists, widely used for the treatment of asthma, strongly relax this smooth muscle (Brittain et al., 1968; Waldeck, 2002) . Therefore, it is generally believed that the catecholamine-induced relaxation of airway smooth muscle is mainly mediated via the β2-subtype of adrenoceptor (β2-receptor). Indeed, based on the pharmacological evidence obtained with multiple β1-and β2-selective antagonists with different pA2 values, we have shown that the primary β-adrenoceptor that mediates the relaxant response to isoprenaline, a synthetic catecholamine that nonselectively recognizes the three β-adrenoceptor subtypes (Johnson et al., 1993) , is the β2-but not the β1-receptor in guinea-pig tracheal smooth muscle (Tanaka et al., 2004b) . This result further suggests an important role for the β2-receptor as the key β-adrenoceptor that controls airway smooth muscle tone and for it being the targeted membrane protein for the pharmacologic therapy of asthma.
On the other hand, there are few studies on the β-adrenoceptor subtype that mediates the relaxation of airway smooth muscle in response to endogenous catecholamines including adrenaline (Lemoine et al., 1985; Lemonine et al., 1989; O'Donnell and Wanstall, 1981) . While these earlier studies have suggested that the β-adrenoceptor subtype mediating adrenalineinduced relaxation is principally β2 rather than β1 (Lemoine et al., 1985; Lemonine et al., 1989 ), this conclusion is based mainly on an analysis using ICI-118,551 (Bilski et al., 1983) as the exclusive β-adrenoceptor antagonist. Furthermore, it is not certain whether the inhibition of the relaxant effect of adrenaline by ICI-118,551 occurs in a competitive manner, since the slope of the Schild plot analysis against adrenaline was less than unity (O'Donnell and Wanstall, 1981) .
In the present study, we provide pharmacological evidence to show that the β2-receptor is the primary subtype involved in the mediation of the relaxant response of guinea-pig tracheal smooth muscle to adrenaline, an adrenal medulla hormone, as is also the case for responses to salbutamol, the well known β2-selective adrenoceptor agonist (Brittain et al., 1968; Koike et al., 2004) .
Materials and methods
Male and female Hartley guinea-pigs weighing 300-600 g (Saitama Experimental Animals, Saitama, Japan) were used in the present study. Guinea-pigs were housed under standard laboratory conditions on a 12-h light/dark cycle (lights on 8 AM; lights off 8 PM) in rooms in which the temperature (20-22°C) and the relative air humidity (50 ± 5%) were strictly regulated.
Food and water were available ad libitum to all animals. The study was conducted in accordance with the Guideline for the Care and Use of Laboratory Animals adopted by the Committee on the Care and Use of Laboratory Animals of Toho University School of Pharmaceutical Sciences (accredited by The Ministry of Education, Culture, Sports, Science, and Technology, Japan).
Preparation of tracheal tissue
Guinea-pigs were killed by cervical dislocation and exsanguinated from the common carotid or external iliac artery. The trachea was carefully isolated and immersed in Ringer-Locke solution (mM: NaCl, 154.0; KCl, 5.6; CaCl2, 2.2; MgCl2, 2.1; NaHCO3, 5.9; glucose, 2.8) bubbled with a mixture of 95% O2 and 5% CO2. The tracheal preparations were very cautiously cleaned of unnecessary adipose and connective tissue under a dissecting microscope to ensure that the smooth muscle was not damaged. Subsequently, the tracheal cartilage containing the smooth muscle was cut into ring preparations of 2-mm in length. The intimal surface of the tracheal tissue was gently rubbed with moistened filter paper to remove tracheal epithelium as much as possible.
Measurement of tension changes
Preparations were suspended using stainless steel hooks (outer diameter, 200 µm) in a 5-ml organ bath (UC-5; UFER Medical Instrument, Kyoto, Japan) containing Ringer-Locke solution which was maintained at 32 ± 1°C and bubbled with the O2-CO2 mixture. Tension changes were isometrically recorded with a force-displacement transducer (T7-8-240; Orientec, Tokyo, Japan) connected to an amplifier (high-gain DC amplifier: model, AD 632J; Nihon Kohden, Tokyo, Japan).
Assessment of the relaxant effects of adrenaline
The relaxant effects of adrenaline were examined as follows. After stretching the preparation with an initial load of 2 g, a spontaneous tension development was generated. During this tension development, the bath solution was renewed every 20 min for 60 min. This spontaneous tension development lasted for several hours without appreciable decline. Following the 60 min tension development period, the muscle was contracted with histamine (10 -5 M) for 15 min, and this was then washed out. After this procedure, the tracheal preparations were incubated for a further 60 min with renewal of the bath solution every 20 min, and were then again contracted with 10 -5 M histamine. When the active tension obtained with histamine and the initial muscle stretch reached a steady-state level about 30 min after the application of histamine, adrenaline was cumulatively applied to the bath medium until the maximum relaxant responses to adrenaline were obtained. At the end of each experiment, papaverine (10 -4 M) was applied to the bath medium to obtain the substantially maximum relaxant response.
Assessment of the effects of β-adrenoceptor antagonists
Antagonistic effects of test drugs (propranolol, bupranolol, atenolol, 712A, butoxamine, 551) were examined as follows. One of the β-adrenoceptor antagonists was applied to the bath medium simultaneously with histamine (10 -5 M). Thirty minutes after the addition of the β-adrenoceptor antagonist, a concentration-response curve for adrenaline was constructed in both the absence and presence of the β-adrenoceptor antagonist. In this study, only a single concentration-response curve was obtained per preparation, whether in the absence or in the presence of β-adrenoceptor antagonists, to prevent possible tachyphylaxis, unexpected interventions by β-adrenoceptor antagonists, or abnormal relaxant responses due to muscle fatigue after repetitive relaxations in the presence of varied concentrations of β-adrenoceptor antagonists.
Drugs (±)-Bupranolol hydrochloride was kindly donated by Kaken Pharmaceutical Co., Ltd. (Tokyo, Japan). Other drugs used in the present study were as follows: histamine dihydrochloride, (-)- 
All other chemicals used were of analytical grade. Distilled water was used to dissolve and dilute all drugs.
Data analysis and statistics
To construct concentration-response relationships for adrenaline and salbutamol, the percentages of the relaxant responses were calculated considering the tension level before application of adrenaline or salbutamol (spontaneous tone plus histamine-elicited tension) to be 0% and the maximum relaxation obtained after application of papaverine (10 -4 M) to be 100%.
Data were plotted as a function of adrenaline or salbutamol concentration and fitted to the equation:
where E is the % relaxation at a given relaxant concentration of either adrenaline or salbutamol, Emax is the maximum relaxation, A is the concentration of relaxants, nH is the slope function and EC50 is the relaxant concentration that produced a 50% response. The curve fitting was carried out using GraphPad Prism™ (Version 3.00) (GraphPad Software, San Diego, Calif., USA). The EC50 values were converted to logarithmic values (pD2, -logEC50) for statistical analysis. The competitive antagonistic potency was expressed as a pA2 value, which was calculated according to the method originally reported by Arunlakshana and Schild (1959) . Data are presented as the mean ± SEM or as the mean value with 95% confidence intervals in parentheses, and n refers to the number of experiments. The significance of the difference between mean values was evaluated with GraphPad Prism™ using the unpaired Student's t-test, or the unpaired t-test with Welch's correction if necessary. A P value of less than 0.05 was considered to be statistically significant.
Results

Effects of propranolol and bupranolol on the relaxation to adrenaline
In the isolated guinea-pig tracheal smooth muscle, adrenaline ( Figs Values of adrenaline and salbutamol were 7.11 ± 0.05 (n=27) and 7.67 ± 0.05 (n=14), respectively. Figure 1 shows the effects of both propranolol and bupranolol, which antagonize β1-/β2-adrenoceptors nonselectively, on the relaxation in response to adrenaline. The concentrationresponse curve for adrenaline was shifted rightwards in a parallel fashion by both propranolol and bupranolol. The regression lines of the Schild plot for propranolol (Fig. 1B) and bupranolol ( Fig. 1D) were not significantly different from unity, which indicates a competitive antagonism by both antagonists of the relaxant response to adrenaline (Table 1 ). The pA2 values for propranolol and bupranolol against adrenaline were calculated as 8.85 and 8.97, respectively, which were consistent with the values against salbutamol (8.69 and 8.94) ( Table 1) .
Effects of atenolol and CGP-20,712A on the relaxation to adrenaline
The concentration-response curve for adrenaline was not affected by atenolol within the concentration ranges ≤ 10 -6 M (n=3). The relaxant response to adrenaline was also not affected by CGP-20,712A (≤ 10 -8 M) (n=3). However, the concentration-response curve for adrenaline ( Fig. 2A) as well as that for salbutamol (Fig. 2B ) was shifted rightwards in a parallel manner by higher concentrations (3 × 10 -6 -3 × 10 -5 M) of atenolol. Schild plot analysis carried out for atenolol against adrenaline and salbutamol yielded straight lines with slopes of unity ( Fig. 2C ; Figure 3A and Fig. 3B show the effects of butoxamine on the relaxations to both adrenaline and salbutamol. Relaxations to both adrenaline (Fig. 3A) and salbutamol (Fig. 3B) were competitively antagonized by butoxamine, which was evidenced by the Schild plot analysis providing straight lines of slopes of unity ( Fig. 3C ; Table 1 ). The pA2 values of butoxamine against adrenaline and salbutamol were identical at 6.86 and 6.85 respectively (Table 1) .
Effects of butoxamine and ICI-118,551 on the relaxations to adrenaline and salbutamol
Similarly, relaxations to both adrenaline (Fig. 3D) and salbutamol (Fig. 3E) were competitively antagonized by ICI-118,551. Its pA2 values against adrenaline (8.73) and salbutamol (8.89) were also not significantly different (P>0.05) from each other (Fig. 3F, Table 1 ). 
Discussion
In this study, using several types of β-adrenoceptor antagonists with different pA2 values, we reached the conclusion that adrenaline as well as salbutamol produces relaxation of guinea-pig tracheal smooth muscle through the mediation of β2-receptors. This deduction was based on the following observations. Firstly, we showed that adrenaline-elicited tracheal relaxation is competitively antagonized by propranolol and bupranolol, both of which nonselectively antagonize β1-/β2-subtypes. This finding indicates that the adrenaline-elicited relaxation of tracheal muscle is mediated through typical β (β1 or β2)-adrenoceptors. The consistency of their pA2 values against both adrenaline and salbutamol (propranolol: 8.85 vs. 8.69; bupranolol: 8.97 vs. 8.94 , Table 1 ) also suggests that the response to this catecholamine is through the mediation of typical β-adrenoceptors, though this finding does not directly indicate the involvement of β2-receptors.
Secondly, adrenaline-elicited tracheal relaxation was found not to be affected by atenolol (≤ 10 -6 M) and CGP-20,712A (≤ 10 -8 M) within their concentration ranges that are supposed to selectively antagonize the β1-subtype: pA2 values of atenolol and CGP-20,712A against the β1-subtype, when obtained in isoprenaline-elicited relaxation in the guinea-pig esophageal smooth muscle, are ≈7.0 (7.01) (Tanaka et al., 2004a) and ≈9.5 (9.43) , respectively. On the other hand, ≥ 3 × 10 -6 M atenolol competitively antagonized the relaxant response to adrenaline ( Fig. 2A) , which was strongly supported by the unitary slope of the Schild plot analysis against adrenaline (Fig. 2C , Table 1 ). The pA2 value of atenolol against adrenaline was 5.77 and this was consistent with the value against salbutamol (5.73), which indicates the mediation of β2-receptor in the response to adrenaline (Table 1) . These pA2 values of atenolol were in good agreement with the previously reported values against fenoterol (5.61) (O'Donnell and Wanstall, 1979) ; and salbutamol (5.71, 5.76) (Keith et al., 1986; Tanaka et al., 2004b) . These observations rule out the β1 but support the β2 as the primary β-adrenoceptor subtype that mediates the relaxation of tracheal smooth muscle to adrenaline. Thirdly, we showed that tracheal relaxation to adrenaline as well as to salbutamol was competitively antagonized by butoxamine (Fig. 3A-C) or ICI-118,551 (Fig. 3D-F (against salbutamol in guinea-pig taenia caecum) (Koike et al., 1997) ; 551, 8.78 and 9.17 (against salbutamol in guinea-pig trachea) (Keith et al., 1986; O'Donnell and Wanstall, 1981) , and 8.81 (against fenoterol in guinea-pig trachea) (O'Donnell and Wanstall, 1981 ).
In conclusion, we have provided evidence to show that the β2-rather than the β1-adrenoceptor plays the primary role in mediating the relaxant response to adrenaline in guineapig tracheal smooth muscle. The present study is the first identification of the β-adrenoceptor subtype mediating adrenaline-induced relaxation of tracheal smooth muscle based on a systematic pharmacological approach using multiple, subtype-selective β-adrenoceptor antagonists with different affinities.
